Format

Send to

Choose Destination
See comment in PubMed Commons below
Assay Drug Dev Technol. 2013 Mar;11(2):101-7. doi: 10.1089/adt.2012.476. Epub 2012 Oct 12.

Label-free cytotoxicity screening assay by digital holographic microscopy.

Author information

1
Biomolecular Screening Facility, Swiss Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.

Abstract

We introduce a label-free technology based on digital holographic microscopy (DHM) with applicability for screening by imaging, and we demonstrate its capability for cytotoxicity assessment using mammalian living cells. For this first high content screening compatible application, we automatized a digital holographic microscope for image acquisition of cells using commercially available 96-well plates. Data generated through both label-free DHM imaging and fluorescence-based methods were in good agreement for cell viability identification and a Z'-factor close to 0.9 was determined, validating the robustness of DHM assay for phenotypic screening. Further, an excellent correlation was obtained between experimental cytotoxicity dose-response curves and known IC50 values for different toxic compounds. For comparable results, DHM has the major advantages of being label free and close to an order of magnitude faster than automated standard fluorescence microscopy.

PMID:
23062077
PMCID:
PMC3593696
DOI:
10.1089/adt.2012.476
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Mary Ann Liebert, Inc. Icon for PubMed Central
    Loading ...
    Support Center